DA

Dunvegan Associates, Inc.

13F
Dunvegan Associates, Inc.
Last update 2017-04-28 197 Stocks (3 new)
Value $83.00 Mil Turnover 3 %
Countries:
Top Holdings:
Dunvegan Associates, Inc. Top Holdings of 2015-12-31 View Full List
Ticker
Company
Shares
Value ($1000)
Shares Change %
Weighting %
Trade Impact %
% of Shares outstanding
3M Change %
YTD Change %
Market Cap $Mil
Industry
MA
Mastercard Inc
97,966
9,538.0
-1.95%
11.520
-0.21%
0.010
+8.33%
+25.55%
488,662.4
Credit Services
MKC
McCormick & Co Inc
158,276
6,771.0
+1.70%
8.180
+0.14%
0.030
-1.60%
+20.99%
21,851.0
Consumer Packaged Goods
V
Visa Inc
72,776
5,644.0
-1.28%
6.820
-0.08%
0.000
+10.32%
+21.62%
608,496.4
Credit Services
LNG
Cheniere Energy Inc
104,283
3,885.0
-3.65%
4.690
-0.22%
0.040
+21.42%
+27.04%
48,155.5
Oil & Gas
LLY
Eli Lilly and Co
41,378
3,486.0
-1.01%
4.210
-0.04%
0.000
-16.19%
+35.09%
703,579.6
Drug Manufacturers
GLD
SPDR Gold Shares ETF
33,996
3,449.0
-2.52%
4.170
-0.11%
0.010
+4.63%
+29.35%
75,048.1
 
XLP
Consumer Staples Select Sector SPDR
66,749
3,370.0
-1.67%
4.070
-0.06%
0.030
-1.31%
+14.19%
17,224.9
 
NVS
Novartis AG
36,627
3,151.0
-0.91%
3.810
-0.04%
0.000
-14.80%
+1.37%
198,004.6
Drug Manufacturers
ACN
Accenture PLC
25,940
2,711.0
-2.09%
3.270
-0.06%
0.000
+3.36%
+4.29%
225,060.5
Software
DELISTED:AGN
Allergan PLC
8,407
2,627.0
-1.78%
3.170
-0.05%
0.000
-1.29%
+1.74%
63,659.1
Drug Manufacturers

Dunvegan Associates, Inc.'s Historical Top Holdings Breakdowns

Dunvegan Associates, Inc. Total Holding History ($B)

To

Dunvegan Associates, Inc.'s Asset Allocation

To

Dunvegan Associates, Inc. Past Portfolios

Portfolio Date Number of Stocks New Stocks Total Value ($Mil) Q/Q Turnover

Top Ranked Articles

  • 1

Dunvegan Associates, Inc.'s Hypothetical Growth since 2015-12-31

Dunvegan Associates, Inc.'s Yearly Returns

Year Portfolio % % Excess Gain %

Dunvegan Associates, Inc.'s Holdings Heat Map

Size field:

Dunvegan Associates, Inc.'s Holdings Bubble Chart

Dunvegan Associates, Inc. News

  • 1

Discussions on Dunvegan Associates, Inc.

No discussions yet.